Key result
Finding ~15% of previously CPVT-associated variants in population exomes suggests they lack high monogenic penetrance.
Observational (n=60,706)
A large proportion of genetic variants previously associated with CPVT are overrepresented in the general population, suggesting they are likely false positives and not highly penetrant monogenic causes of the disease.
Answers are grounded in this paper and cite their sources.
Many CPVT variants may be reclassified as benign; challenges prior associations and leaves open refined curation for clinical testing.
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a highly lethal cardiac arrhythmia disease occurring during exercise or psychological stress. CPVT has an estimated prevalence of 1:10,000 and has mainly been associated with variants in calcium-regulating genes. Identification of potential false-positive pathogenic variants was conducted by searching the Exome Aggregation Consortium (ExAC) database (n = 60,706) for variants reported to be associated with CPVT. The pathogenicity of the interrogated variants was assessed using guidelines from the American College of Medical Genetics and Genomics (ACMG) and in silico prediction tools. Of 246 variants 38 (15%) variants previously associated with CPVT were identified in the ExAC database. We predicted the CPVT prevalence to be 1:132. The ACMG standards classified 29% of ExAC variants as pathogenic or likely pathogenic. The in silico predictions showed a reduced probability of disease-causing effect for the variants identified in the exome database (p < 0.001). We have observed a large overrepresentation of previously CPVT-associated variants in a large exome database. Based on the frequency of CPVT in the general population, it is less likely that the previously proposed variants are associated with a highly penetrant monogenic form of the disease.
No takes yet. Share an insight, caveat, or question.
Paludan‐Müller et al. (2016) conducted an observational in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) (n=60,706). Previously CPVT-associated variants was evaluated on Presence of previously CPVT-associated variants in the ExAC database (p=<0.001). Analysis of 60,706 exomes revealed a large overrepresentation of previously CPVT-associated variants, suggesting they are less likely to cause a highly penetrant monogenic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: